2009
DOI: 10.1186/1756-0500-2-95
|View full text |Cite
|
Sign up to set email alerts
|

The bioactivity of plant extracts against representative bacterial pathogens of the lower respiratory tract

Abstract: BackgroundLower respiratory tract infections are a major cause of illness and death. Such infections are common in intensive care units (ICU) and their lethality persists despite advances in diagnosis, treatment and prevention. In Mexico, some plants are used in traditional medicine to treat respiratory diseases or ailments such as cough, bronchitis, tuberculosis and other infections. Medical knowledge derived from traditional societies has motivated searches for new bioactive molecules derived from plants tha… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
26
1
2

Year Published

2012
2012
2017
2017

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 33 publications
(30 citation statements)
references
References 28 publications
1
26
1
2
Order By: Relevance
“…Antibacterial and antimycobacterial assays were determined as previously described in the literature (Camacho‐Corona et al ., ; Bocanegra‐García et al ., ). An institutional ethical committee has approved this work.…”
Section: Methodsmentioning
confidence: 97%
See 1 more Smart Citation
“…Antibacterial and antimycobacterial assays were determined as previously described in the literature (Camacho‐Corona et al ., ; Bocanegra‐García et al ., ). An institutional ethical committee has approved this work.…”
Section: Methodsmentioning
confidence: 97%
“…In previous studies we carried out a screening of 36 extracts obtained from nine plants used in Mexican traditional medicine to treat respiratory infections including tuberculosis. The results of those studies showed that the chloroformic extract of Larrea tridentata had activity against methicillin resistant (MR) Staphylococcus aureus BAA‐44 (MIC 250 µg/mL), Bacillus subtilis (MIC 62.25 µg/mL), Lysteria monocytogenes (MIC 125 µg/mL), Acinetobacter baumannii (MIC 125 µg/mL) (Bocanegra‐García et al ., ) and a sensitive (MIC 200 µg/mL) and four monoresistant strains of M. tuberculosis H37Rv (MIC 100–200 µg/mL) (Camacho‐Corona et al ., ). Thus, we carried out the isolation and characterization of active compounds from L. tridentata .…”
Section: Introductionmentioning
confidence: 99%
“…Although, new generations of antibiotics were produced by pharmacological companies,the drug resistance has been increased (Tenover, 2006 andChovanová et al, 2013). This situation has forced the scientists attention towards natural and herbal products to develop better quality drugs with improved antibacterial activities (Bako et al,2005;Sibanda & Okoh, 2007;Bocanegra-Garcia et al, 2009 andSaranraj, 2014 ). Djeussi et al (2013), provided useful baseline information for the potential use of some edible plants in the fight against both sensitive and multidrug-resistant (MDR) phenotypes.…”
Section: Introductionmentioning
confidence: 99%
“…The antimicrobial potential of different medicinal plants is being extensively studied all over the world, but only a few studies have been carried out in a systematic manner [2]. Medical knowledge derived from traditional societies has motivated searches for new bioactive molecules derived from plants that show potent activity against bacterial pathogens [3]. Nowadays, some researchers are providing laboratory trials to justify for the use of the plants in folk medicine to treat various infectious diseases [4].…”
Section: Introductionmentioning
confidence: 99%